DNA X, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
DNA X, Inc. (SONM) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $99.84 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-05-20
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-31 was $99.84.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2022-03-31 was $23.29, a 140.10% increase year-over-year.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2021-03-31 was $9.70, a 181.98% increase year-over-year.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2020-03-31 was $3.44, a 273.91% increase year-over-year.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $33.65, a 22.14% increase from fiscal 2021.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2021 was $27.55, a 41.72% decline from fiscal 2020.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2020 was $47.27, a 573.36% increase from fiscal 2019.
- DNA X, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2019 was $7.02, a 1050.82% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $99.84 10-Q · filed 2026-05-20 | ||||
| 2022-12-31 | $33.65 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $33.65 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $26.84 10-Q · filed 2022-08-12 | ||||
| 2022-03-31 | $23.29 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | $27.55 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $27.55 10-Q/A · filed 2022-06-29 | ||||
| 2021-06-30 | $2.92 10-Q/A · filed 2022-06-29 | ||||
| 2021-03-31 | $9.70 10-Q · filed 2021-05-11 | ||||
| 2020-12-31 | $47.27 10-K/A · filed 2022-06-29 | $4.73 10-K · filed 2021-03-18 | |||
| 2020-09-30 | $4.73 10-Q · filed 2020-11-12 | ||||
| 2020-06-30 | $4.91 10-Q · filed 2020-08-12 | ||||
| 2020-03-31 | $3.44 10-Q · filed 2020-05-14 | ||||
| 2019-12-31 | $7.02 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $6.64 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $1.53 10-Q · filed 2019-08-13 | ||||
| 2019-03-31 | $0.92 10-Q · filed 2019-06-24 | ||||
| 2018-12-31 | $0.61 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CLEARONE INC (CLRO) | United States | $0.009B | |
| FRANKLIN WIRELESS CORP (FKWL) | United States | $0.028B | -61.80 |
| FiEE, Inc. (FIEE) | Japan | $0.033B | 8.06 |
| Clearfield, Inc. (CLFD) | United States | $0.415B | -74.88 |
| ADTRAN Holdings, Inc. (ADTN) | United States | $0.565B | -43.25 |
| Fabrinet (FN) | $14.287B | 39.79 | |
| CIENA CORP (CIEN) | United States | $50.874B | 81.72 |